Detalhe da pesquisa
1.
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.
Br J Cancer
; 128(2): 354-362, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357702
2.
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours.
Br J Cancer
; 124(2): 391-398, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020594
3.
Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial.
Br J Cancer
; 122(5): 634-639, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919404
4.
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
Br J Cancer
; 122(8): 1166-1174, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147669
5.
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.
Liver Int
; 40(1): 215-228, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31579990
6.
The yield of chest computed tomography in patients with locally advanced pancreatic cancer.
J Surg Oncol
; 122(3): 450-456, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32378193
7.
Chemoprevention in Patients with Peutz-Jeghers Syndrome: Lessons Learned.
Oncologist
; 23(4): 399-e33, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371475
8.
FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study.
J Surg Oncol
; 118(6): 1021-1026, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259526
9.
Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma.
Acta Oncol
; 57(11): 1467-1474, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943624
10.
Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform.
Lancet Oncol
; 23(2): 198-201, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114116
11.
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Lancet Reg Health Eur
; 39: 100875, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464480
12.
Evaluation of patient enrollment in oncology phase I clinical trials.
Oncologist
; 18(3): 323-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23429738
13.
A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors.
Invest New Drugs
; 31(2): 399-408, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23161335
14.
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
Future Oncol
; 9(1): 13-20, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23252559
15.
Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
Dig Surg
; 29(6): 522-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23548745
16.
Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.
Clin Pharmacol Ther
; 111(2): 455-460, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656072
17.
First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial.
Ther Adv Med Oncol
; 14: 17588359221077088, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251315
18.
A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers.
Clin Cancer Res
; 28(1): 71-83, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615725
19.
Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer.
Biomed Pharmacother
; 153: 113393, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834987
20.
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302562